Studying TAK-243 in Patients With Advanced Cancer

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: UAE Inhibitor TAK-243 Sponsors: National Cancer Institute (NCI) Not yet recruiting

https://clinicaltrials.gov/study/NCT06223542

Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials